NCT06539390

Brief Summary

Radicular low back pain due to disc herniation is frequently observed. There are rest, medical treatments, physical medicine modalities, interventional procedures for pain and surgical options in the treatment of lumbar disc herniations. Epidural interventional methods can be applied safely and effectively in patients who do not respond to conservative treatment. Transforaminal epidural steroid injections (TFESE) are frequently used in the interventional treatment of lumbosacral radicular low back pain. TFESE is applied targetedly under fluoroscopy guidance in disc herniation. Therefore, the chance of success increasesTFESE, which is considered a minimally invasive procedure today, is frequently preferred in interventional pain treatments. TFESE can be performed with or without sedation, depending on the preference of the physician and the patient, the patient's comorbidities, the infrastructure of the hospital and the health presentation. There are conflicting and limited studies on whether sedation is necessary in interventional pain procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
201

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

April 24, 2024

Last Update Submit

January 18, 2026

Conditions

Keywords

Transforaminal Epidural Injections, Sedation,Pain

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale-11 (NRS-11)

    It is an 11-point numerical scale where patients can rate their pain on a scale of 0 (no pain) to 10 (the most severe pain they have ever felt).

    one month

Secondary Outcomes (1)

  • Likert scale

    four days

Study Arms (1)

Is Sedation Necessary for Transforaminal Epidural Injections

Other: Transforaminal Epidural Injections?

Interventions

Pain, lumbar disc herniation,Transforaminal Epidural Injections?

Also known as: Is Sedation Necessary for Transforaminal Epidural Injections?
Is Sedation Necessary for Transforaminal Epidural Injections

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Exclusion Criteria: * Patients with ASA 4 and above, * patients with a history of lumbar surgery, * patients with multi-level disc herniation, * malignancy, * psychosis, * patients without MRI imaging, * patients with known allergies to the drugs used, * patients with bleeding disorders, * patients with infection at the injection site, and pregnant patients were excluded from the study.

You may qualify if:

  • Patients aged 18-65, American Society of Anesthesiologists (ASA) 1-3, who underwent unilateral, single-level TFESE were included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Süleyman Training and Research Hospital

Istanbul, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pain specialist

Study Record Dates

First Submitted

April 24, 2024

First Posted

August 6, 2024

Study Start

April 1, 2024

Primary Completion

August 1, 2024

Study Completion

August 30, 2025

Last Updated

January 21, 2026

Record last verified: 2026-01

Locations